Industry Growth Insights published a new data on “Computational Drug Discovery Market”. The research report is titled “Computational Drug Discovery Market research by Types (Structure-based Drug Design (SBDD), Ligand-based Drug Design (LBDD), Sequence-based Approaches), By Applications (Oncological Disorders, Neurological Disorders, Immunological Disorders, Infectious Diseases, Others), By Players/Companies AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro, BOC Sciences, Aris Pharmaceuticals, ChemDiv, RTI International, XRQTC, Pharmaron”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Computational Drug Discovery Market Research Report
By Type
Structure-based Drug Design (SBDD), Ligand-based Drug Design (LBDD), Sequence-based Approaches
By Application
Oncological Disorders, Neurological Disorders, Immunological Disorders, Infectious Diseases, Others
By Companies
AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro, BOC Sciences, Aris Pharmaceuticals, ChemDiv, RTI International, XRQTC, Pharmaron
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Computational Drug Discovery Market Report Segments:
The global Computational Drug Discovery market is segmented on the basis of:
Types
Structure-based Drug Design (SBDD), Ligand-based Drug Design (LBDD), Sequence-based Approaches
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncological Disorders, Neurological Disorders, Immunological Disorders, Infectious Diseases, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AMRI
- Charles River
- Schrödinger
- Evotec
- Bayers
- GVK Biosciences
- AstraZeneca
- BioDuro
- BOC Sciences
- Aris Pharmaceuticals
- ChemDiv
- RTI International
- XRQTC
- Pharmaron
Highlights of The Computational Drug Discovery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Structure-based Drug Design (SBDD)
- Ligand-based Drug Design (LBDD)
- Sequence-based Approaches
- By Application:
- Oncological Disorders
- Neurological Disorders
- Immunological Disorders
- Infectious Diseases
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Computational Drug Discovery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Computational drug discovery is the process of discovering new drugs by using computer algorithms to predict how a particular drug will interact with other molecules in the body.
Some of the major companies in the computational drug discovery market are AMRI, Charles River, Schr¶dinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro, BOC Sciences, Aris Pharmaceuticals, ChemDiv, RTI International, XRQTC, Pharmaron.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Computational Drug Discovery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Computational Drug Discovery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Computational Drug Discovery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Computational Drug Discovery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Computational Drug Discovery Market Size & Forecast, 2018-2028
4.5.1 Computational Drug Discovery Market Size and Y-o-Y Growth
4.5.2 Computational Drug Discovery Market Absolute $ Opportunity
Chapter 5 Global Computational Drug Discovery Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Computational Drug Discovery Market Size Forecast by Type
5.2.1 Structure-based Drug Design (SBDD)
5.2.2 Ligand-based Drug Design (LBDD)
5.2.3 Sequence-based Approaches
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Computational Drug Discovery Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Computational Drug Discovery Market Size Forecast by Applications
6.2.1 Oncological Disorders
6.2.2 Neurological Disorders
6.2.3 Immunological Disorders
6.2.4 Infectious Diseases
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Computational Drug Discovery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Computational Drug Discovery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Computational Drug Discovery Analysis and Forecast
9.1 Introduction
9.2 North America Computational Drug Discovery Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Computational Drug Discovery Market Size Forecast by Type
9.6.1 Structure-based Drug Design (SBDD)
9.6.2 Ligand-based Drug Design (LBDD)
9.6.3 Sequence-based Approaches
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Computational Drug Discovery Market Size Forecast by Applications
9.10.1 Oncological Disorders
9.10.2 Neurological Disorders
9.10.3 Immunological Disorders
9.10.4 Infectious Diseases
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Computational Drug Discovery Analysis and Forecast
10.1 Introduction
10.2 Europe Computational Drug Discovery Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Computational Drug Discovery Market Size Forecast by Type
10.6.1 Structure-based Drug Design (SBDD)
10.6.2 Ligand-based Drug Design (LBDD)
10.6.3 Sequence-based Approaches
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Computational Drug Discovery Market Size Forecast by Applications
10.10.1 Oncological Disorders
10.10.2 Neurological Disorders
10.10.3 Immunological Disorders
10.10.4 Infectious Diseases
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Computational Drug Discovery Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Computational Drug Discovery Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Computational Drug Discovery Market Size Forecast by Type
11.6.1 Structure-based Drug Design (SBDD)
11.6.2 Ligand-based Drug Design (LBDD)
11.6.3 Sequence-based Approaches
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Computational Drug Discovery Market Size Forecast by Applications
11.10.1 Oncological Disorders
11.10.2 Neurological Disorders
11.10.3 Immunological Disorders
11.10.4 Infectious Diseases
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Computational Drug Discovery Analysis and Forecast
12.1 Introduction
12.2 Latin America Computational Drug Discovery Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Computational Drug Discovery Market Size Forecast by Type
12.6.1 Structure-based Drug Design (SBDD)
12.6.2 Ligand-based Drug Design (LBDD)
12.6.3 Sequence-based Approaches
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Computational Drug Discovery Market Size Forecast by Applications
12.10.1 Oncological Disorders
12.10.2 Neurological Disorders
12.10.3 Immunological Disorders
12.10.4 Infectious Diseases
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Computational Drug Discovery Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Computational Drug Discovery Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Computational Drug Discovery Market Size Forecast by Type
13.6.1 Structure-based Drug Design (SBDD)
13.6.2 Ligand-based Drug Design (LBDD)
13.6.3 Sequence-based Approaches
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Computational Drug Discovery Market Size Forecast by Applications
13.10.1 Oncological Disorders
13.10.2 Neurological Disorders
13.10.3 Immunological Disorders
13.10.4 Infectious Diseases
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Computational Drug Discovery Market: Competitive Dashboard
14.2 Global Computational Drug Discovery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AMRI
14.3.2 Charles River
14.3.3 Schrödinger
14.3.4 Evotec
14.3.5 Bayers
14.3.6 GVK Biosciences
14.3.7 AstraZeneca
14.3.8 BioDuro
14.3.9 BOC Sciences
14.3.10 Aris Pharmaceuticals
14.3.11 ChemDiv
14.3.12 RTI International
14.3.13 XRQTC
14.3.14 Pharmaron
